BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29

• BioMimetic Therapeutics, Inc.'s Clinical Investigators To Receive Award From American Academy Of Periodontology For Outstanding Publication; Clinical Investigators To Present Data At Annual AAP Meeting

  September 14, 2006

   · 

  1 min read
• Business

  Calgenex Corporation Names Joseph Jacobs, M.D., As Consulting Medical Director

  September 14, 2006

   · 

  1 min read
• BioMidwest

  Tripos Announces Support For Open-Source Workflow Software; Preview Version Of The Tripos Chemistry Extensions For The KNIME Open-Source Workflow Platform Now Available

  September 14, 2006

   · 

  1 min read
• Drug Development

  ZIOPHARM, Inc. Presents At European Society Of Hematology Meeting; Updates ZIO-101 Clinical Development Strategy

  September 14, 2006

   · 

  1 min read
• Policy

  Courts In Pennsylvania And Texas Grant Isolagen, Inc. Dismissal Of Shareholder Derivative Suits

  September 14, 2006

   · 

  1 min read
• Drug Development

  Merck & Co., Inc. Release: New Phase III Data Showed Significant Glucose-Lowering Efficacy Of JANUVIA(TM), An Investigational Medicine For Type 2 Diabetes, When Taken Simultaneously With Metformin

  September 14, 2006

   · 

  1 min read
• Business

  Restech Corp. Recruits Joel Richter, M.D. To All-Star Scientific Advisory Board

  September 14, 2006

   · 

  1 min read
• Drug Development

  MannKind Biopharmaceuticals Completes Patient Enrollment For The Major Phase 3 Safety Study Of Technosphere(R) Insulin In Patients With Diabetes

  September 14, 2006

   · 

  1 min read
• Drug Development

  Takeda Pharmaceuticals North America, Inc. Release: ACTOS(R) (Pioglitazone HCl) Demonstrates Significant Improvements In Cardiovascular Outcomes For High-Risk Patients With Type 2 Diabetes

  September 14, 2006

   · 

  1 min read
• Business

  Crucell N.V. Announces STAR(TM) Technology Research License Agreement

  September 14, 2006

   · 

  1 min read